Copenhagen biopharmaceutical manufacturing facility expanded to support growing customer demand for clinical and commercial production Copenhagen, Denmark / Seattle, Washington USA – October 15, 2013 ...
As resources become less accessible – both in terms of funding and personnel - smaller or emerging sponsors are unlikely to have a large Chemistry, Manufacturing and Controls (CMC) group. In fact, in ...
Dublin, April 14, 2026 (GLOBE NEWSWIRE)-- The "Digital CMC: The Key To Realising Pharma 4.0 (June 23, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical and ...
Dublin, April 10, 2026 (GLOBE NEWSWIRE)-- The "Digital CMC (May 6, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical and biotech industries are under increasing ...
According to Gustavo F. Mahler, Ph.D., Global Chief Operations Officer of CMC Biologics, "The expansion of the facility to include the 2,000L SUB will allow us to meet increasing demand for producing ...
CMC ICOS Biologics, Inc. a global leader in clinical and commercial manufacturing of therapeutic proteins, and Harpoon Therapeutics, an immuno-oncology company using a proprietary TriTAC™ technology ...
Developing innovative pharmaceutical drugs and technologies is a complicated process. A robust chemistry, manufacturing, and controls (CMC) strategy is critical to determining a new drug’s success or ...
Chemistry, Manufacturing and Controls (CMC): are all stages of the drug development life cycle, after drug discovery. During preclinical drug development, the proper analytical methods are validated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results